Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment
恩杂鲁胺和阿比特龙治疗后通过靶向 3βHSD1 治疗前列腺癌
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2022.100608
Zejie Mei, Tao Yang, Ying Liu, Yuanyuan Gao, Zemin Hou, Qian Zhuang, Dongyin He, Xuebin Zhang, Qilong Tan, Xuyou Zhu, Yingyi Qin, Xi Chen, Chengdang Xu, Cuidong Bian, Xinan Wang, Chenyang Wang, Denglong Wu, Shengsong Huang, Zhenfei Li
